Abstract

ABSTRACT Aim: Type 2 diabetes can cause serious vascular problems. Abnormal plateletcrit (PCT) levels were shown as a risk factor for coronary artery diseases by recent studies. Glycosylated hemoglobin (HbA1c) is a widely used marker for the assessment of glycemic control. This study aimed to evaluate the relationship between HbA1c and PCT. Material and Method: It is a retrospective case-control study. 63 type 2 diabetic patients’ and 51 healthy control individuals’ records were evaluated. Platelet indices were compared. Correlation between HbA1c and PCT, MPV was investigated in type 2 diabetes patients. Results: Type 2 diabetes patients have a difference with MPV (p<0,001) but no difference with PCT (p=0.65) by comparing healthy controls. Between HbA1c and PCT levels, a statistically significant correlation was detected (r=0,4 p<0,01). Any correlation wasn’t detected with MPV. Conclusion: Plateletcrit may be guided for preventing vascular complication due to poor glycemic regulation. Therefore patients with increased plateletcrit values should be evaluated for a higher risk of vascular complications.

Authors and Affiliations